Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spero Therapeutics, Inc. | 75,000 | reported | 12 Jun 2025 | tx 11+108,378 |
| CRITICAL THERAPEUTICS INC | 71,033 | reported | 22 Aug 2007 | tx 13+1,213,033 |
| Larimar Therapeutics, Inc. | 55,150 | reported | 19 May 2026 | tx 15+240,477 |
| ADVANCED MAGNETICS INC | 30,000 | reported | 23 Feb 2017 | tx 43+511,200−91,705 |
| ESPERION THERAPEUTICS INC/MI | 0 | reported | 10 Feb 2004 | tx 4+46,799−197,778 |
| Orchard Therapeutics plc | 0 | reported | 24 Jan 2024 | tx 45+3,659,354−3,794,392 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Larimar Therapeutics, Inc. | 55,150 | 0.00 USD | deriv |
| 27 Feb 2026 | PURCHASE | Larimar Therapeutics, Inc. | 5,000 | 5.00 USD | first after silence |
| 12 Jun 2025 | GRANT_AWARD | Spero Therapeutics, Inc. | 20,000 | 0.00 USD | |
| 13 May 2025 | GRANT_AWARD | Larimar Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | Larimar Therapeutics, Inc. | 19,000 | 0.00 USD | deriv |
| 29 May 2024 | GRANT_AWARD | Spero Therapeutics, Inc. | 20,000 | 0.00 USD | |
| 14 Feb 2024 | PURCHASE | Larimar Therapeutics, Inc. | 2,000 | 11.00 USD | first after silence |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 92,081 | — | |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 199,990 | 0.00 USD | deriv |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 179,390 | 0.00 USD | deriv |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 405,590 | 0.00 USD | deriv |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 75,000 | 0.00 USD | deriv |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 457,800 | 0.00 USD | deriv |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 335,000 | 0.00 USD | deriv |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 27,730 | 0.00 USD | deriv |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 99,980 | 0.00 USD | deriv |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 149,990 | 0.00 USD | deriv |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 309,990 | 0.00 USD | deriv |
| 05 Oct 2023 | GRANT_AWARD | Spero Therapeutics, Inc. | 20,000 | 0.00 USD | |
| 09 May 2023 | GRANT_AWARD | Larimar Therapeutics, Inc. | 8,300 | 0.00 USD | deriv |
| 10 Mar 2023 | EXERCISE | Orchard Therapeutics plc | 20,000 | 0.46 USD | |
| 10 Mar 2023 | EXERCISE | Orchard Therapeutics plc | 20,000 | 0.00 USD | deriv |
| 01 Mar 2023 | GRANT_AWARD | Orchard Therapeutics plc | 405,600 | 0.00 USD | deriv |
| 01 Mar 2023 | GRANT_AWARD | Orchard Therapeutics plc | 179,400 | 0.00 USD | deriv |
| 09 Feb 2023 | EXERCISE | Orchard Therapeutics plc | 20,000 | 0.46 USD |
4 purchases reported after at least 12 months of silence — most recent on 27 Feb 2026.